TGThe Guardian·2hBusiness
score+0.60
GSK to buy US cancer treatment firm Nuvalent for $10.6bn
Original
GSK to buy US cancer treatment firm Nuvalent for $10.6bn
“Celebratory tone emphasizing major corporate deal, strategic growth, and leadership achievement with constructive framing.”